NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Verve Medical

Verve Medical

Private
Phoenix, ArizonaHealthcare & Life Scienceshttps://www.verve-medical.com/

Last Round

Series D

May 13, 2025

Total Funding Raised

$11.74M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Verve Medical is a clinical-stage medical device company that develops novel transurethral renal pelvic denervation devices to treat uncontrolled hypertension.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

renal pelvic denervationRPDuncontrolled hypertensionradiofrequency ablationminimally invasive surgerymedical devicetransurethral procedurerenal denervationinterventional cardiologyurologynephrologymedtechclinical-stage

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Verve Medical Comparables

Compare Verve Medical with similar companies based on industry and business-model similarity.

Verve Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ablative Solutions
81%
Cortex, Inc.
79%
Symple Surgical
77%

Verve Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DMay 13, 2025
Early FundingOct 25, 2016
Series BAug 21, 2013
Series AJul 31, 2012

Key People

Founding team and executive leadership

David Perry

President & CEO

Executive Team

Randy Buness

CFO

Executive Team

Verve Medical Investors

Notable investors and investment history

Verve Medical investors
InvestorRounds
HM Venture PartnersSeries D
LongRiver InvestmentsSeries D

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 13, 2026

    Monthly visitors increased 48% MoM.

  • May 3, 2026

    Grew 50% QoQ, from 8 to 12 employees.

Verve Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Verve Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Verve Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersPhoenix, Arizona
Employee Range13
Year Founded2011
Last FundingMay 13, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.